Immune Response to Marburg Virus Angola Infection in Nonhuman Primates

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S234-S241

  Fernando, Lisa ^a   Qiu, Xiangguo ^a,b   Melito, P Leno ^a   Williams, Kinola J N ^a,c   Feldmann, Friederike ^a   Feldmann, Heinz ^a,b   Jones, Steven M ^a   Alimonti, Judie B ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Department of Medical Microbiology ^*  (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

cynomolgus macaques; cytokines; Ebolavirus; Filovirus; lymphocytes; Marburg Angola; Marburgvirus; natural killer cells; nonhuman primates

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANGOLA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOKINE STORM; DEATH; DEPRESSION; FEMALE; FEVER; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LYMPHOCYTOPENIA; MACACA FASCICULARIS; MARBURG HEMORRHAGIC FEVER; NATURAL KILLER CELL; NONHUMAN; PETECHIA; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; VIRUS VIRULENCE; ANIMAL; DISEASE MODEL; EBOLAVIRUS; IMMUNOLOGY; LYMPHOCYTE; MACACA; MARBURGVIRUS; PRIMATE; VIROLOGY; VIRULENCE;

ANGOLA; ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; EBOLAVIRUS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-6; LYMPHOCYTES; MACACA; MARBURG VIRUS DISEASE; MARBURGVIRUS; PRIMATES; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 84943277353     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv095     Document Type: Article

References (39)

1. Siegert R, Shu HL, Slenczka W, Peters D, Muller G. On the etiology of an unknown human infection originating from monkeys. Dtsch Med Wochenschr 1967; 92:2341-3.
2. Slenczka WG. The Marburg virus outbreak of 1967 and subsequent episodes. Curr Top Microbiol Immunol 1999; 235:49-75.
3. Gear JS, Cassel GA, Gear AJ, et al. Outbreake of Marburg virus disease in Johannesburg. Br Med J 1975; 4:489-93.
4. Johnson ED, Johnson BK, Silverstein D, et al. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl 1996; 11:101-14.
5. Smith DH, Johnson BK, Isaacson M, et al. Marburg-virus disease in Kenya. Lancet 1982; 1:816-20.
6. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006; 355:909-19.
7. Colebunders R, Tshomba A, Van Kerkhove MD, et al. Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: Clinical documentation, features of illness, and treatment. J Infect Dis 2007; 196(suppl 2):S148-53.
8. World Health Organization (WHO). Marburg haemorrhagic fever- update 25. Geneva: WHO, 2005. http://www.who.int/csr/don/2005-08-24/en/index.html. Accessed 10 February 2012.
9. Towner JS, Khristova ML, Sealy TK, et al. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 2006; 80:6497-516.
10. Roddy P, Weatherill D, Jeffs B, et al. The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. II lessons learned in the community. J Infect Dis 2007; 196(suppl 2):S162-7.
11. Jeffs B, Roddy P, Weatherill D, et al. The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I lessons learned in the hospital. J Infect Dis 2007; 196(suppl 2):S154-61.
12. Roddy P, Thomas SL, Jeffs B, et al. Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola. J Infect Dis 2010; 201:1909-18.
13. Alves DA, Glynn AR, Steele KE, et al. Aerosol exposure to the Angola strain of Marburg virus causes lethal viral hemorrhagic fever in cynomolgus macaques. Vet Pathol 2010; 47:831-51.
14. Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, et al. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol 2006; 80:9659-66.
15. Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, et al. Marburg virus angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis 2007; 196(suppl 2):S372-81.
16. Geisbert TW, Bailey M, Geisbert JB, et al. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. J Virol 2010; 84:10386-94.
17. Thi EP, Mire CE, Ursic-Bedoya R, et al. Marburg virus infection in nonhuman primates: therapeutic treatment by lipid-encapsulated siRNA. Sci Transl Med 2014; 6:250ra116.
18. Geisbert TW, Daddario-Dicaprio KM, Geisbert JB, et al. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine 2008; 26:6894-900.
19. Qiu X, Fernando L, Alimonti JB, et al. Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong Ebola GP-specific immune responses. PLoS One 2009; 4:e5547.
20. Reed DS, Mohamadzadeh M. Status and challenges of filovirus vaccines. Vaccine 2007; 25:1923-34.
21. Gupta M, Spiropoulou C, Rollin PE. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro. Virology 2007; 364:45-54.
22. Hensley LE, Alves DA, Geisbert JB, et al. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. J Infect Dis 2011; 204(suppl 3):S1021-31.
23. Warren TK, Warfield KL, Wells J, et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med 2010; 16:991-4.
24. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000; 80:171-86.
25. Stroher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H. Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 2001; 75:11025-33.
26. Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS. Cellular immune response to Marburg virus infection in cynomolgus macaques. Viral Immunol 2008; 21:355-63.
27. Qiu X, Audet J, Wong G, et al. Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 2012; 4:138ra81.
28. Geisbert TW, Geisbert JB, Leung A, et al. Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus. J Virol 2009; 83:7296-304.
29. Warren TK, Wells J, Panchal RG, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014; 508:402-5.
30. Swenson DL, Warfield KL, Larsen T, Alves DA, Coberley SS, Bavari S. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines 2008; 7:417-29.
31. Swenson DL, Wang D, Luo M, et al. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clin Vaccine Immunol 2008; 15:460-7.
32. Riemenschneider J, Garrison A, Geisbert J, et al. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine 2003; 21:4071-80.
33. Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror 2011; 9:361-71.
34. Bray M, Mahanty S. Ebola hemorrhagic fever and septic shock. J Infect Dis 2003; 188:1613-7.
35. Mohamadzadeh M, Chen L, Schmaljohn AL. How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007; 7: 556-67.
36. Geisbert TW, Young HA, Jahrling PB, et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 2003; 163:2371-82.
37. Valmas C, Grosch MN, Schumann M, et al. Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog 2010; 6:e1000721.
38. Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 1996; 70:2208-14.
39. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal Zaire ebolavirus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010; 4:pii:e837.